Jubilant Pharmova
JUBLPHARMA.NS
#4312
Rank
โ‚น171.62 B
Marketcap
โ‚น1,083
Share price
-0.80%
Change (1 day)
105.03%
Change (1 year)

Revenue for Jubilant Pharmova (JUBLPHARMA.NS)

Revenue in 2024 (TTM): โ‚น68.74 Billion

According to Jubilant Pharmova's latest financial reports the company's current revenue (TTM ) is โ‚น69.97 Billion. In 2023 the company made a revenue of โ‚น65.59 Billion an increase over the revenue in the year 2022 that were of โ‚น60.72 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jubilant Pharmova from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น68.74 B4.8%
2023 โ‚น65.59 B8.01%
2022 โ‚น60.72 B-0.39%
2021 โ‚น60.96 B-9.27%
2020 โ‚น67.19 B-18.42%
2019 โ‚น82.36 B-7.13%
2018 โ‚น88.68 B31.06%
2017 โ‚น67.66 B17.72%
2016 โ‚น57.48 B0.73%
2015 โ‚น57.06 B-1.69%
2014 โ‚น58.04 B4.43%
2013 โ‚น55.58 B